Evidence map›Paper›PMID 35844981›Full record

ArticleEJHaem2020

Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review.

Solo Traoré, Mehdi Roumila, Pirayeh Eftekhari, Hassan Farhat, Fatiha Merabet, Oumar Guira, Philippe Rousselot, Reza Azarian, Caroline Besson

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Solo TraoréTraining and Research Unit in Health Sciences Joseph Ki ZERBO University Ouagadougou Burkina Faso.
Mehdi RoumilaDepartment of Pneumology Versailles Hospital Center Le Chesnay France.ORCID https://orcid.org/0000-0002-1723-5960
Pirayeh EftekhariFrench Regional Pharmacovigilance Center Fernand-Widal Hospital-APHP Paris France.
Hassan FarhatDepartment of Hematology-Oncology Versailles Hospital Center Le Chesnay France.
Fatiha MerabetDepartment of Hematology-Oncology Versailles Hospital Center Le Chesnay France.
Oumar GuiraTraining and Research Unit in Health Sciences Joseph Ki ZERBO University Ouagadougou Burkina Faso.
Philippe RousselotDepartment of Hematology-Oncology Versailles Hospital Center Le Chesnay France.
Reza AzarianDepartment of Pneumology Versailles Hospital Center Le Chesnay France.
Caroline BessonDepartment of Hematology-Oncology Versailles Hospital Center Le Chesnay France.ORCID https://orcid.org/0000-0003-4364-7173
Centre Hospitalier de Versailles · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FRUniversité Joseph Ki-Zerbo · BFAssistance Publique – Hôpitaux de Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35844981
PMCPMC9176077
OpenAlexW3100750363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.